HK-listed Lee’s Pharmaceutical unit nets $145m co-led by Hillhouse, TPG Asia

HK-listed Lee’s Pharmaceutical unit nets $145m co-led by Hillhouse, TPG Asia

Photo: Pixabay

Zhaoke Ophthalmology Pharmaceutical (ZKO), an indirect subsidiary of Hong Kong-listed Lee’s Pharmaceutical Holdings Limited, has garnered as much as $145 million in its Series B round co-led by Hillhouse Capital’s Hillhouse COFL and TPG Asia, per a filing with the Stock Exchange of Hong Kong (HKEx) on October 11. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter